BioSpace News Archive

Pharm Country

Rocket Pharmaceuticals Announces Participation at the Bank of America Merrill Lynch 2019 Healthcare Conference

Rocket Pharmaceuticals, Inc. announces that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket is scheduled to present on Wednesday, May 15, 2019, at 3:40p.m.

May 7, 2019
·
1 min read
Business

Charles River Laboratories Announces First-Quarter 2019 Results

Charles River Laboratories International, Inc. reported its results for the first quarter of 2019.

May 7, 2019
·
27 min read
Drug Development

Ra Pharmaceuticals Announces Positive gMG Phase 2 and Open-Label, Long-Term Extension Data at the 2019 AAN Annual Meeting

Open-label, long-term extension data show durability of zilucoplan treatment effect, with sustained improvements observed in primary and secondary endpoints at 24 weeks

May 7, 2019
·
9 min read
Pharm Country

The Medicines Company to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference

The Medicines Company announced that it will participate in the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14, 2019, in Las Vegas.

May 7, 2019
·
1 min read
Pharm Country

Data from Pivotal FIREFISH and SUNFISH Studies Demonstrate Clinical Benefit of Risdiplam in Type 1, 2, & 3 Spinal Muscular Atrophy Patients

Babies with Type 1 SMA from Part 1 of FIREFISH continue to achieve motor milestones including standing

May 7, 2019
·
10 min read
Policy

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome

May 7, 2019
·
3 min read
Deals

IRRAS Strengthens Position in Neurocritical Care by Acquiring Proprietary Assets, Including Four US FDA-cleared Products

Assets complement IRRAflow® and support positioning as a leading company in the space

May 7, 2019
·
3 min read
Deals

Confo Therapeutics Raises €30 Million in Series A Financing

Round led by BioGeneration Ventures and co-led by Wellington Partners, with investments by Fund+, Perceptive Advisors and existing investors

May 7, 2019
·
3 min read
Business

Half-year Figures: ZEISS Innovations Help Achieve Strong Growth

The ZEISS Group had a successful end to the first six months of fiscal year 2018/19 and saw its revenue rise by 9 percent to EUR 3.019 billion.

May 7, 2019
·
2 min read
Pharm Country

Legal-Bay Pre Settlement Funding Expects Delays in IVC Filter Settlements

Leading lawsuit funding company says Bard and Cook continue to contend liability.

May 7, 2019
·
2 min read